Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

One-Way ANOVA: Unequal Sample Sizes

One-Way ANOVA: Unequal Sample Sizes

One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of the PD-L1 CPS With the Efficacy of First-Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer.

Cancer medicine·2026

Same author

Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular Carcinoma.

Liver cancer·2026

Same author

Response to Zhang and Lu.

Journal of the National Cancer Institute·2026

Same author

Consultation rates, comorbidities, and prescriptions for menopausal disorders among Japanese working women: a descriptive study using a nationwide administrative insurance claims database.

Maturitas·2026

Same author

A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin Combination Using Machine Learning.

Cancers·2026

Same author

Association between modifiable lifestyle factors and the incidences of sudden sensorineural hearing loss and Meniere's disease: A population-based nested case-control study.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026

Search research articles

Related Experiment Video

Updated: May 17, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

A modified maximum contrast method for unequal sample sizes in pharmacogenomic studies.

Kengo Nagashima¹, Yasunori Sato, Chikuma Hamada

¹Josai University.

Statistical Applications in Genetics and Molecular Biology

|October 24, 2012

Summary

This summary is machine-generated.

Biomedical researchers can improve pharmacogenomic analysis with a new modified maximum contrast method. This approach offers a more powerful and accurate way to detect true biological response patterns compared to existing methods.

Related Experiment Videos

Last Updated: May 17, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Area of Science:

Pharmacogenomics
Biomedical Research
Statistical Analysis

Background:

Traditional methods like Kruskal-Wallis and ANOVA in pharmacogenomics can reduce power for detecting expected biological response patterns.
Previous methods, such as the permuted modified maximum contrast, have limitations due to dependence on nuisance parameters (population variance, σ2).

Purpose of the Study:

To propose a novel modified maximum contrast method for pharmacogenomic studies.
To develop a statistic that is independent of the nuisance parameter σ2.
To compare the performance of the new method against existing techniques via simulation.

Main Methods:

Development of a modified maximum contrast statistic.
Simulation studies to compare the proposed method with Kruskal-Wallis, ANOVA, and the permuted modified maximum contrast method.
Evaluation of false-positive rates and power to detect true response patterns.

Main Results:

The modified maximum contrast method demonstrated the lowest false-positive rate in simulations.
The proposed method is powerful for detecting true biological response patterns under specific conditions.
The modified maximum contrast method is faster and more accurate than the permuted modified maximum contrast method.

Conclusions:

The modified maximum contrast method offers an improved statistical approach for pharmacogenomic studies.
This method provides higher accuracy and power in identifying genotype-biological response associations.
A guideline is suggested for selecting the most appropriate statistical method based on study conditions.